Stock Events

Stock Events

Fulgent Genetics 

$19.73
150
+$0.08+0.41% Friday 20:00

Statistics

Day High
19.81
Day Low
19.73
52W High
31.04
52W Low
13.46
Volume
12,111
Avg. Volume
-
Mkt Cap
542.88M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.65
-0.39
-0.12
0.14
Expected EPS
-0.65
Actual EPS
N/A

Financials

-18.75%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
322.67MRevenue
-60.51MNet Income

Analyst Ratings

15.00Average Price Target
The highest estimate is 15.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FLGT. It's not an investment recommendation.
Apple
33
AAPL
Tesla
30
TSLA
Microsoft
28
MSFT
NVIDIA
28
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genetic testing market.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing in the broader genetic testing market.
Myriad Genetics
MYGN
Mkt Cap302.25M
Myriad Genetics offers molecular diagnostic tests, including for cancer and other diseases, directly competing with Fulgent.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen provides sample and assay technologies for molecular diagnostics, competing in the genetic testing market.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences offers sequencing systems, competing in the genetic information market.
Bionano Genomics
BNGO
Mkt Cap13.78M
Bionano Genomics provides tools for genetic research and diagnostics, competing in the genomic analysis sector.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a wide range of solutions for genetic analysis and diagnostics, competing in the life sciences sector.
Intellia Therapeutics
NTLA
Mkt Cap1.8B
Intellia Therapeutics is involved in CRISPR gene editing, a technology that could compete with traditional genetic testing by offering novel treatments and diagnostics.

About

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
Show more...
CEO
Ming Hsieh
Employees
1315
Country
United States
ISIN
US3596641098
WKN
000A2AS4N

Listings

STU
DE
7F0.STU
MU
DE
7F0.MU
XNAS
US
FLGT
MX
MX
FLGT.MX

0 Comments

Share your thoughts

FAQ

What is Fulgent Genetics stock price today?▼
The current price of FLGT is $19.73 USD — it has increased by +0.41% in the past 24 hours. Watch Fulgent Genetics stock price performance more closely on the chart.
What is Fulgent Genetics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Fulgent Genetics stocks are traded under the ticker FLGT.
Is Fulgent Genetics stock price growing?▼
FLGT stock has risen by +0.61% compared to the previous week, the month change is a +6.48% rise, over the last year Fulgent Genetics has showed a -10.11% decrease.
What is Fulgent Genetics market cap?▼
Today Fulgent Genetics has the market capitalization of 542.88M
When is the next Fulgent Genetics earnings date?▼
Fulgent Genetics is going to release the next earnings report on November 06, 2026.
What were Fulgent Genetics earnings last quarter?▼
FLGT earnings for the last quarter are -0.58 USD per share, whereas the estimation was -0.46 USD resulting in a -26.09% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Fulgent Genetics revenue for the last year?▼
Fulgent Genetics revenue for the last year amounts to 322.67M USD.
What is Fulgent Genetics net income for the last year?▼
FLGT net income for the last year is -60.51M USD.
How many employees does Fulgent Genetics have?▼
As of September 05, 2026, the company has 1,315 employees.
In which sector is Fulgent Genetics located?▼
Fulgent Genetics operates in the Health & Wellness sector.
When did Fulgent Genetics complete a stock split?▼
Fulgent Genetics has not had any recent stock splits.
Where is Fulgent Genetics headquartered?▼
Fulgent Genetics is headquartered in EL MONTE, United States.